Infusive Asset Management’s Clorox CLX Stock Holding History

Infusive Asset Management’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-744	Closed	-$144K	–	61
2021 Q1	$144K	Buy	744 +90	+14%	+$17.3K	0.03%	46
2020 Q4	$132K	Buy	+654	New	+$135K	0.04%	42

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CRC

Cedar Rock Capital London, United Kingdom $4.05B AUM 21.89% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Infusive Asset Management's CLX Position: Q2 2021 in Review

Infusive Asset Management sold out of Clorox (CLX) in Q2 2021, closing a stake of 744 shares — an estimated $144K sold.

Infusive Asset Management first reported a position in CLX in Q4 2020 and held it in 2 quarters. The position peaked at $144K in Q1 2021. 1,168 funds tracked by Wall St. Rank hold CLX as of Q2 2021.

Infusive Asset Management reported no remaining Clorox position as of Q2 2021 after selling out during the quarter.
Infusive Asset Management sold 744 Clorox shares in Q2 2021, an estimated $144K.
Infusive Asset Management first reported a position in Clorox in Q4 2020 and held it in 2 quarters.
Infusive Asset Management's Clorox position peaked at $144K in Q1 2021.
1,168 funds tracked by Wall St. Rank held Clorox as of Q2 2021.

Based on Infusive Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.